Li-Cor Biotech, LLC

Li-Cor Biotech, LLC, a Lincoln, Nebraska-based for-profit limited liability partnership, manufactures and sells advanced scientific imaging systems and related support services to federal research and medical institutions as a prime contractor, operating exclusively in the full-and-open competitive space with no set-aside designation across nine recent federal awards totaling $446 thousand in combined potential value.

Li-Cor's capability portfolio centers on the Odyssey series of imaging systems — specialized analytical laboratory instruments for Western blot imaging, fluorescence detection, protein and nucleic acid analysis, and tissue section imaging at 5-micron resolution — delivered as equipment purchases and bundled with installation, training, and preventive maintenance support. Representative recent work includes a $92 thousand sole-source purchase order from the National Cancer Institute in June 2026 for an Odyssey M Chemi/Fluor Imaging Bundle with four solid-state laser diodes (488, 520, 685, and 785 nm wavelengths), sCMOS fluorescence detection, and CCD luminescence detection capability, including 30-to-45-day delivery, onsite OEM-certified installation, and 12-month warranty; a $75 thousand firm-fixed-price purchase order from the National Institute of Allergy and Infectious Diseases in September 2024 for an Odyssey M Fluor Bundle Imaging System to support the Laboratory of Viral Diseases; and a $71 thousand purchase order from the National Human Genome Research Institute in September 2025 for a 4-laser scientific imaging system. Beyond equipment sales, Li-Cor provides maintenance and support contracts; recent examples include a $12.5 thousand premium support base-year order from Veterans Integrated Service Network 10 running through April 2029 and a $10 thousand annual service agreement for preventive maintenance and repairs at the Michael E. DeBakey VA Medical Center in Houston, Texas.

Customer concentration is split between research institutes within the National Institutes of Health and the Department of Veterans Affairs health networks. By dollar value, the top five customers account for 82% of combined potential value: the National Cancer Institute ($92 thousand), the National Institute of Allergy and Infectious Diseases ($75 thousand), the Air Force Academy ($74 thousand), the National Human Genome Research Institute ($72 thousand), and Veterans Integrated Service Network 22 ($53 thousand). By award count, Veterans Integrated Service Network 10 appears twice (two awards, $49 thousand combined), while the remaining six customer agencies each hold one award. Li-Cor operates exclusively as a prime contractor with no subcontract footprint in the source data. Activity remains light — four awards in 2024, two in 2025, three in 2026 — and only one award ($72 thousand) reaches ultimate completion within the next twenty-four months, presenting a modest recompete exposure window.